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A 65 year old, multiparous, postmenopausal female status-post total
hysterectomy with bilateral salpingo-oophorectomy 39 years prior for
symptomatic myomatous uterus, presented for her annual well
woman exam. She was without complaints and review of systems was
negative; speciﬁcally, she denied any recent history of unintended
weight loss or gain, fever, chills, nausea, melena or hematochezia,IntroductionWhile over 90% of vulvar malignancies are squamous cell carcino-
mas, other histologic types include melanomas, basal cell carcinomas,
sarcomas, extramammary Paget's disease, and Bartholin gland adeno-
carcinomas. Although rare, breast tissue arising in the vulva can also
have malignant potential. “Ectopic breast tissue” in the vulva was ﬁrst
described by Hartung in 1872, and since that time, several cases of
both benign and malignant lesions arising in vulvar mammary tissue
have been reported (van der Putte, 1994). The histology of the
mammary-like tissue has multiple forms, ranging from simple, wide,
slightly coiled tubular glandswith a smooth outline, tomore complicat-
ed forms inwhich the coiled structure has numerous branches and acini
forming lobules. Similar to normal breast tissue, both epithelial and
myoepithelial cells are present and the glands are subject to both the
dysplastic and malignant changes that are seen in normal breast tissue
(van der Putte, 1994).We report a case of amammary-like invasive car-
cinoma presenting as an asymptomatic vulvar nodule.g of Obstetrics andGynecology,
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-NC-SA license. vaginal bleeding or discharge, abdominal pain or fullness. Her last
mammogram was 1–2 years prior, after which she was diagnosed
with right breast ductal papilloma which was excised. Colorectal
screening was up to date.
In addition to her prior hysterectomy, gynecologic history was
signiﬁcant for estrogen replacement therapy for 20 years, which she
stopped after developing what she reported as “vaginal cysts.” Two
years prior to presentation, she had such a lesion removed from her
right labia that had been present for one year and pathologywas benign,
per patient. On further discussion, she reported that the lesion had
returned, was not painful, and was not associated with any further
growth for the last six months. Clinical breast examination did not
demonstrate evidence of palpable masses, retraction, skin changes, or
axillary adenopathy. Genital examination revealed a mobile, soft, non-
tender, 2.5 × 0.75 cm nodule at 11 o'clock on her right labia majora.
Excisional biopsy was performed in clinic, which revealed ductal
carcinoma in situ with positive margins. The patient then underwent a
wide local excision of the area, which pathologically revealed invasive
carcinoma with negative margins.
The specimen from the wide local excision revealed a surface which
was predominantly dark brown andwrinkledwith a smooth, white, ﬂat
lesion measuring 0.8 × 0.3 cm; the lesion was 1.2 cm from the 12
o'clockmargin and 0.4 cm from the nearest (3 o'clock)margin. On serial
sectioning, the lesion was ﬁrm and white, and extended to a depth of
0.3 cm.
Microscopic examination revealed invasive carcinoma, at least
1.6 mm in greatest dimension (Fig. 1), arising fromwithin a background
ofmammary-like glands of the vulva demonstrating residual focal DCIS.
The invasive lesionwas noted to comewithin 1.3 mmof themargin, but
all margins were negative for invasive disease. The histologic features
were consistent with a primary carcinoma, not a metastatic lesion.
Immunohistochemical (IHC) stains including smooth-muscle heavy
chain (SMM-HC), CD 10, and p63 were performed and while there
appeared to be some myoepithelial cells present along the smooth
contoured edge by SMM-HC only, there were other areas without any
deﬁnitive basal cell/myoepithelial cell staining (Fig. 2). The area of
Fig. 2. Myosin (SMM-HC) stain — This image demonstrates loss of the myoepithelial cell
(MEC) layer, which is considered the gold standard for the diagnosis of invasive cancer.
An intact MEC layer is seen in both benign and in situ lesions.
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lobulocentric) and was not associated with the prior biopsy site
changes. The residual mammary-like ducts (Fig. 3) exhibited strong
immunoreactivity for all 3 IHC stains. The tissue was then tested for
hormone receptor status, and was found to be estrogen receptor (ER)
positive, but progesterone receptor (PR) and HER2/CEP17 negative.
Secondary to narrow margins, re-excision was performed as well as
an ipsilateral groin sentinel lymph node dissection, both of which were
negative for DCIS or malignancy. After referral to a medical oncologist,
shewas also administered letrozole, an aromatase inhibitor, as adjuvant
therapy for the ER positive cancer. 18 months after excision, she iswith-
out evidence of recurrent disease.
Comment
A relative paucity of reports has documented complications of ectop-
ic breast tissue in the vulva, beginningwith Hartung in 1872.Mammary
ridges were theorized to have developed in a line from the axilla to the
groin, and while the large majority of these ridges would normally
regress, it was possible for rudimentary tissue to persist and develop
into supernumerary mammary tissue (van der Putte, 1994). These
mammary-like glands have an unknown function, but were distin-
guished fromeccrine and apocrine glands. The glands are simple tubular
structures and are sparsely concentrated; however, in some women
they are more numerous and assume more complicated forms that
resemblemammary tissue (van der Putte, 1994). Themore complicated
forms contain the basic coiled structure, but are obscured by numerous
branches and acini which form lobules. They are distinctly different
from eccrine and apocrine glands by multiple factors including: 1) the
type of epithelium, 2) the formation of diverticula, branches, and lobuli,
3) the shedding of clusters of epithelium, and 4) the expression of
receptors for estrogen and progesterone.
Additionally, mammary-like glands are also noted to be different
than normal mammary tissue derived from the mammary ridges for
multiple reasons as well: 1) their simpler conﬁguration, 2) the higher
number of glands than would be expected in rudimentary elements
from mammary ridges, and 3) the direct relationship to eccrine glands.
Furthermore, based on human embryologic studies, the mammary
ridges could not involve the anogenital area, as at the height of the
formation of the mammary ridges in 9 mm and 10 mm embryos, the
labia majora are still far from their ﬁrst appearance (van der Putte,
1994). However, ectopic breast tissue has been described in the vulva,
as well as in any other area of the body. Both ectopic breast tissue and
mammary-like glands are susceptible to the physiologic, dysplastic,
and malignant changes seen in normal breast parenchyma (Castro and
Deavers, 2001), as there have been reported cases of invasive ductalFig. 1. Invasive carcinoma in greatest dimension.carcinoma, ductal carcinoma in situ (DCIS), lobular carcinoma, mucin-
ous adenocarcinoma, phyllodes tumors, and ﬁbroadenomas in accesso-
ry breast tissue in the vulva (Lopes et al., 2006).
Although ectopic mammary tissue in the vulva is believed to be
present in two to six percent of women, few cases of invasive ductal
carcinoma have been reported in the literature (Kazakov et al., 2011).
The most common clinical presentation is a painless, solitary nodule,
arising most often in the labia majora. Patient age at presentation has
been between 45 and 84 years, with most being 60 or older (Kazakov
et al., 2011). Most carcinoma cases are histologically consistent with
invasive ductal carcinoma, which is also the most common histology
in orthotopic breast tissue (Kazakov et al., 2011). This still leaves a dif-
ferential diagnosis of primary mammary carcinoma, carcinoma of a
skin appendage, or metastatic mammary carcinoma. Recognition of an
in situ component is the best clue to establishing the primary origin in
the skin, as was seen in our case, rather than a metastatic process
(Kazakov et al., 2011).
Secondary to the rarity of these lesions, there is no widely accepted
recommended management strategy. A recent review only identiﬁed
approximately 25 cases reported in the literature (Benito et al., 2013).
Management strategies have ranged from wide local excision for DCIS
to radical vulvectomy with bilateral inguinofemoral nodal dissection
for invasive carcinomas (Irvin et al., 1999). Adjuvant therapies have in-
cluded radiation, anthracycline-based chemotherapy, and hormonalFig. 3. Focal mammary-like duct near the margins, without atypia.
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Patients that did not receive adjuvant therapy had a median survival
of 4 months (Lopes et al., 2006). Only 1 patient out of 8 who received
adjuvant therapy had died at the time of the previous publications,
and the median survival was greater than 22 month (Lopes et al.,
2006; Irvin et al., 1999). Not surprisingly, there have been no clinical
trials to evaluate the effectiveness of chemotherapy and radiation in
such a small number of patients, so information on treatment has
been, and should continue to be, extrapolated from treatment of cancers
in the breast — i.e. excisional procedure with or without lymph node
dissection, followed by other adjuvant therapies as needed.
There is little to no data reporting on the utility of sentinel lymph
node biopsy in this clinical scenario. Breast carcinoma is almost exclu-
sively managed using sentinel lymph node mapping (Krag et al., 2010),
while promising data support the use of this technique for vulvar cancer
(Levenback et al., 2012). Vulvar cancer is ideally suited for sentinel
lymph node mapping secondary to the predictable lymphatic drainage
of the vulva, the low false negative rate, and the substantially reduced
morbidity (e.g. lymphedema) compared to a full groin lymph node dis-
section (Levenback et al., 2012). We demonstrate this to be a potentially
feasible technique for primary breast adenocarcinomas arising within
the vulva in mammary-like glands, and in the context of such a rare his-
tology, may be included in the management options of this disease.Conﬂict of interest statement
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